[HTML][HTML] Radiochemistry for positron emission tomography

J Rong, A Haider, TE Jeppesen, L Josephson… - Nature …, 2023 - nature.com
Positron emission tomography (PET) constitutes a functional imaging technique that is
harnessed to probe biological processes in vivo. PET imaging has been used to diagnose …

Developing new molecular imaging probes for PET

K Serdons, A Verbruggen, GM Bormans - Methods, 2009 - Elsevier
Positron emission tomography (PET) is a fully translational molecular imaging technique that
requires specific probes radiolabelled with short-lived positron emitting radionuclides. This …

Positron emission tomography: applications in drug discovery and drug development

J Wang, L Maurer - Current topics in medicinal chemistry, 2005 - ingentaconnect.com
Positron Emission Tomography (PET) is a sophisticated nuclear imaging modality that
affords researchers the ability to conduct both functional and molecular imaging on …

Chemistry for Positron Emission Tomography: Recent Advances in 11C‐, 18F‐, 13N‐, and 15O‐Labeling Reactions

X Deng, J Rong, L Wang, N Vasdev… - Angewandte Chemie …, 2019 - Wiley Online Library
Positron emission tomography (PET) is a molecular imaging technology that provides
quantitative information about function and metabolism in biological processes in vivo for …

Molecular tracers for the PET and SPECT imaging of disease

SL Pimlott, A Sutherland - Chemical Society Reviews, 2011 - pubs.rsc.org
The development of positron emission tomography (PET) and single photon emission
computed tomography (SPECT) imaging continues to grow due to the ability of these …

Synthesis of 11C, 18F, 15O, and 13N Radiolabels for Positron Emission Tomography

PW Miller, NJ Long, R Vilar… - Angewandte Chemie …, 2008 - Wiley Online Library
Positron emission tomography (PET) is a powerful and rapidly developing area of molecular
imaging that is used to study and visualize human physiology by the detection of positron …

[HTML][HTML] Insight into the Development of PET Radiopharmaceuticals for Oncology

J Lau, E Rousseau, D Kwon, KS Lin, F Bénard, X Chen - Cancers, 2020 - mdpi.com
While the development of positron emission tomography (PET) radiopharmaceuticals
closely follows that of traditional drug development, there are several key considerations in …

Radiopharmaceutical chemistry for positron emission tomography

Z Li, PS Conti - Advanced drug delivery reviews, 2010 - Elsevier
Molecular imaging is an emerging technology that allows the visualization of interactions
between molecular probes and biological targets. Molecules that either direct or are subject …

The next generation of positron emission tomography radiopharmaceuticals in oncology

SL Rice, CA Roney, P Daumar, JS Lewis - Seminars in nuclear medicine, 2011 - Elsevier
Although 18 F-fluorodeoxyglucose (18 F-FDG) is still the most widely used positron emission
tomography (PET) radiotracer, there are a few well-known limitations to its use. The last …

A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new?

S Vallabhajosula, L Solnes, B Vallabhajosula - Seminars in nuclear …, 2011 - Elsevier
Positron emission tomography (PET)/computed tomography (CT) is a rapidly expanding
imaging modality, thanks to the availability of compact medical cyclotrons and automated …